Clinical features of sjogren's syndrome in patients with multiple sclerosis

Acta Neurologica Scandinavica

Volumn 124, Issue 2, 2011, Pages 109-114

  Annunziata, P ^a   De Santi, L ^a   Di Rezze, S ^b   Millefiorini, E ^b   Capello, E ^c   Mancardi, G ^c   De Riz, M ^d   Scarpini, E ^d   Vecchio, R ^e   Patti, F ^e  

^a UNIVERSITY OF SIENA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

Glatiramer acetate; Immunomodulatory therapies; Interferon beta; Multiple sclerosis; Sjogren's syndrome

Indexed keywords

BETA1A INTERFERON; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GADOLINIUM; GLATIRAMER; INTERFERON BETA SERINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; QUESTIONNAIRE; SJOEGREN SYNDROME;

ADULT; ANTIRHEUMATIC AGENTS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; OBSERVATION; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 79960133332     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01428.x     Document Type: Article

References (19)

1. Noseworthy JH, Bass BH, Vandervoort MK et al. The prevalence of primary Sjogren's syndrome in a multiple sclerosis population. Ann Neurol 1989;25:95-8.
2. Miro J, Pena-Sagredo JL, Berciano J, Insua S, Leno C, Velarde R. Prevalence of primary Sjogren's syndrome in patients with multiple sclerosis. Ann Neurol 1990;27:582-4.
3. Sandberg-Wollheim M, Axell T, Hansen B et al. Primary Sjogren's syndrome in patients with multiple sclerosis. Neurology 1992;42:845-7.
4. Alexander EL, Malinow K, Lejewski JE et al. Primary Sjogren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986;104:323-30.
5. Delalande S, De Seze J, Fauchais AL et al. Neurologic manifestations in primary Sjogren's syndrome. A study of 82 patients. Medicine 2004;83:280-91.
6. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11:229.
7. Tsai K-Y, Tsai C-P, Liao N. Sjogren's syndrome with central nervous system involvement presenting as multiple sclerosis with failure response to beta-interferon. Eur Neurol 2001;45:59-60.
8. De Santi L, Costantini MC, Annunziata P. Long time interval between multiple sclerosis onset and occurrence of primary Sjogren's syndrome in a woman treated with interferon-beta. Acta Neurol Scand 2005;112:194-6.
9. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-7.
10. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
11. Kassan SS, Moutsopulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004;164:1275-84.
12. Gunal DI, Afsar N, Tanridag T, Aktan S. Autonomic dysfunction in multiple sclerosis: correlation with disease-related parameters. Eur Neurol 2002;48:1-5.
13. Flachenecker P. Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis. J Neurol 2007;254(Suppl 2):96-101.
14. Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV. Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 2001;7:327-34.
15. De Seze J, Stojkovic T, Gauvrit JY et al. Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates. J Neurol 2001;248:297-303.
16. De Seze J, Devos D, Castelnovo G et al. The prevalence of Sjogren's syndrome in patients with primary progressive multiple sclerosis. Neurology 2001;57:1359-63.
17. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-51.
18. Patti F. Cognitive impairment in multiple sclerosis. Mult Scler 2009;15:2-8.
19. Thanou-Stravaki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum 2008;37:273-92.